184 related articles for article (PubMed ID: 31436242)
1. Evaluation of surgery plus postoperative radiotherapy or definitive radiotherapy in older patients with thoracic esophageal squamous cell cancer.
Jiang W; Sun X; Zhou B; Han C; Liu F; Zheng J; Sun X
J Cancer Res Ther; 2019; 15(4):849-856. PubMed ID: 31436242
[TBL] [Abstract][Full Text] [Related]
2. Postoperative radiotherapy for the young-old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience.
Ding W; Yang M; Jiang W; Ge X; Sun X; Zhou B; Liu F; Jiang K; Shen F; Sun X
Medicine (Baltimore); 2020 Apr; 99(17):e19453. PubMed ID: 32332598
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
[TBL] [Abstract][Full Text] [Related]
4. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
[TBL] [Abstract][Full Text] [Related]
5. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
[TBL] [Abstract][Full Text] [Related]
6. Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: Analysis of surveillance, epidemiology, and end results database.
Yu J; Ouyang W; Li Y; Hu J; Xu Y; Wei Y; Liao Z; Liu Y; Zhang J; Xie C
Cancer Med; 2019 Jan; 8(1):21-27. PubMed ID: 30561117
[TBL] [Abstract][Full Text] [Related]
7. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
[TBL] [Abstract][Full Text] [Related]
8. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
Chen J; Yin W; Yao H; Gu W
Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
[TBL] [Abstract][Full Text] [Related]
9. Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy.
Pao TH; Chang WL; Chiang NJ; Chang JS; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
Radiat Oncol; 2020 Sep; 15(1):221. PubMed ID: 32962730
[TBL] [Abstract][Full Text] [Related]
10. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
Lu N; Wang X; Li C; Wang L; Chen JQ; Zhang WC; Wang XM; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Xiao ZF; Zhu SC; Han C; Qiao XY; Pang QS; Wang P; Zhao YD; Sun XC; Zhang KX; Li L; Li GF; Liu ML; Wang YD
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):139-144. PubMed ID: 32135649
[No Abstract] [Full Text] [Related]
12. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
13. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two-center study.
Ni W; Chen J; Xiao Z; Yu S; Zhang W; Zhou Z; Chen D; Feng Q; Chen X; Lin Y; Zhu K; Gao S; Xue Q; Mao Y; Cheng G; Sun K; Liu X; Fang D
Thorac Cancer; 2019 Jun; 10(6):1431-1440. PubMed ID: 31102336
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer.
Xu Y; Liu J; Du X; Sun X; Zheng Y; Chen J; Li B; Liu W; Jiang H; Mao W
Radiat Oncol; 2013 May; 8():116. PubMed ID: 23656920
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy.
Yang GQ; Mhaskar R; Rishi A; Naghavi AO; Frakes JM; Almhanna K; Fontaine J; Pimiento JM; Hoffe SE
Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 30597022
[TBL] [Abstract][Full Text] [Related]
17. Value and application of trimodality therapy or definitive concurrent chemoradiotherapy in thoracic esophageal squamous cell carcinoma.
Lin WC; Ding YF; Hsu HL; Chang JH; Yuan KS; Wu ATH; Chow JM; Chang CL; Chen SU; Wu SY
Cancer; 2017 Oct; 123(20):3904-3915. PubMed ID: 28608916
[TBL] [Abstract][Full Text] [Related]
18. Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.
Voncken FEM; van der Kaaij RT; Sikorska K; van Werkhoven E; van Dieren JM; Grootscholten C; Snaebjornsson P; van Sandick JW; Aleman BMP
Am J Clin Oncol; 2018 Sep; 41(9):919-926. PubMed ID: 28763327
[TBL] [Abstract][Full Text] [Related]
19. The impact of the nodal status on the overall survival of non-surgical patients with esophageal squamous cell carcinoma.
Zhao Z; Zhang Y; Wang P; Wang X; Li M
Radiat Oncol; 2019 Sep; 14(1):161. PubMed ID: 31481064
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis on surgery with or without postoperative radiotherapy to treat squamous cell esophageal carcinoma.
Lin HN; Chen LQ; Shang QX; Yuan Y; Yang YS
Int J Surg; 2020 Aug; 80():184-191. PubMed ID: 32659390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
